Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity
Clinical Trial Grant
Duke Scholars
Principal Investigator
William Raymond Herzog
Medicine, Cardiology
Awarded By
Novo Nordisk, Inc.
Start Date
May 24, 2019
End Date
July 18, 2024
Awarded By
Novo Nordisk, Inc.
Start Date
May 24, 2019
End Date
July 18, 2024
